These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21501702)

  • 1. The natural history of retinal vein occlusion: what do we really know?
    Decroos FC; Fekrat S
    Am J Ophthalmol; 2011 May; 151(5):739-741.e2. PubMed ID: 21501702
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retinal venous occlusion].
    Piguet B
    Rev Med Suisse Romande; 1996 Jan; 116(1):31-5. PubMed ID: 8871272
    [No Abstract]   [Full Text] [Related]  

  • 3. Central retinal vein occlusion study.
    Sangha KS
    Indian J Ophthalmol; 1997 Dec; 45(4):261-2. PubMed ID: 9567028
    [No Abstract]   [Full Text] [Related]  

  • 4. Branch retinal vein occlusion: classification and treatment.
    Parodi MB; Bandello F
    Ophthalmologica; 2009; 223(5):298-305. PubMed ID: 19372724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for improving visual acuity in ischaemic branch retinal vein occlusion using argon laser.
    Zaidi FH; Gair EJ; Gregory-Evans K
    Eye (Lond); 2004 Mar; 18(3):316-8. PubMed ID: 15004585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal vein occlusion: beyond the acute event.
    Ehlers JP; Fekrat S
    Surv Ophthalmol; 2011; 56(4):281-99. PubMed ID: 21601903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of laser spot diameter on the reproducibility of visual field analysis in diabetic patients with upper temporal retinal vein occlusion.
    Akar Y; Apaydin KC; Metinsoy M
    Ophthalmologica; 2008; 222(2):64-8. PubMed ID: 18303224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
    Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
    Retina; 2009; 29(7):932-40. PubMed ID: 19584651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [News in management of retinal vein occlusion].
    Bîscă M
    Oftalmologia; 2010; 54(3):51-7. PubMed ID: 21137190
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Spaide RF; Chang LK; Klancnik JM; Yannuzzi LA; Sorenson J; Slakter JS; Freund KB; Klein R
    Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of macular edema from retinal vein occlusions: you can never have too many choices.
    Bressler NM; Schachat AP
    Ophthalmology; 2010 Jun; 117(6):1061-3. PubMed ID: 20522334
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of laser coagulation of central retinal vein occlusion].
    Lang GE
    Klin Monbl Augenheilkd; 1993 Oct; 203(4):247-51. PubMed ID: 7509425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal vein occlusions: case reviews of USAF aviators.
    Flynn WJ; Green RP; LoRusso FJ
    Aviat Space Environ Med; 1994 Apr; 65(4):332-7. PubMed ID: 8002915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser photocoagulation in retinal vein occlusion: branch vein occlusion study and central vein occlusion study recommendations.
    Saxena S
    Indian J Ophthalmol; 1997 Jun; 45(2):125-8. PubMed ID: 9475033
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence.
    Bansal A; Singh S; Agarwal M; Chauhan L; Venkatesh R; Mayor R
    Retina; 2015 Oct; 35(10):e59. PubMed ID: 26398556
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion.
    Ohashi H; Oh H; Nishiwaki H; Nonaka A; Takagi H
    Ophthalmology; 2004 Nov; 111(11):2050-6. PubMed ID: 15522371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion. Results of a proof of concept study.
    Tan CS; Lim LW; Singer M; Sadda SR
    Graefes Arch Clin Exp Ophthalmol; 2014 Oct; 252(10):1689-90. PubMed ID: 25095764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of laser coagulation of retinal branch vein occlusions].
    Lang GE; Händel A
    Klin Monbl Augenheilkd; 1993 Sep; 203(3):180-8. PubMed ID: 8264208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.